Home » Topics » BioWorld Science

BioWorld Science
RSS

Chimeric spike mRNA-LNP vaccines show cross-protection against Sarbecovirus strains in vivo

Sep. 27, 2021

Discovery of novel EP3 receptor antagonists

Sep. 27, 2021

Second Genome collaborates with VCU to generate biomarker for NASH with advanced fibrosis

Sep. 27, 2021

Ventus outlines NLRP3 inhibitor program

Sep. 27, 2021

Potent inhibitor of sAC shows potential as nonhormonal contraceptive

Sep. 27, 2021

NLRP3 inflammasome inhibitors patented by Cadila Healthcare

Sep. 27, 2021

Servier discovers nuclear factor erythroid 2-related factor 2 activators

Sep. 27, 2021

Kallyope presents new free fatty acid FFA1 receptor agonists

Sep. 27, 2021

Japan Tobacco describes new PDHK2 inhibitors

Sep. 27, 2021

Perampanel ameliorates development of alpha-syn pathology in models of PD

Sep. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.